Jason Johnson

Partner & CHS Managing Director

Overview

Jason Johnson is a partner in Crowell’s Health Care and Privacy & Cybersecurity Groups, where he draws on his experience as a former research scientist to advise clients on complex compliance, legal, regulatory, and transactional matters. He helps clients in the health care and life sciences industries navigate data privacy and cybersecurity issues under U.S. and European law. He also offers strategic insights to assist clients with product development, marketing, clinical research, and other core business initiatives.

Jason is well-versed on even the most complicated regulatory challenges that his clients face. As a former research scientist in academic and pharmaceutical settings, as well as a clinical research monitor who trained physicians, Jason knows the rules firsthand. He employs this knowledge to assist clients with the full range of issues that arise in the research and development process, including drafting and negotiating research, clinical trial, licensing, and manufacturing agreements; intellectual property and technology transfer issues; collection, transfer and sharing of data, including patient registries and bio-repositories; and advising clients on mergers and acquisitions and related transactions. Jason’s clients in this area include academic medical centers, healthcare technology companies, emerging to late stage biotechnology companies, pharmaceutical and medical device companies, and other health care and research organizations.

In addition, Jason counsels hospitals, home health agencies, and other health care providers on state and federal fraud and abuse issues including the Stark Law and the Anti-Kickback Statute.

Jason also has extensive experience as a patent litigator. He represented pharmaceutical and chemical companies in Hatch-Waxman litigation for more than 11 years. Jason has substantial experience in counseling clients regarding patent portfolio management, including reviewing patent portfolios, providing advice on the strength or weakness of those portfolios and what actions should be taken, if any, to best protect the company’s products and assets.

Career & Education

|
    • University of North Carolina at Chapel Hill, B.S.
    • Franklin Pierce Law Center, J.D., magna cum laude
    • University of North Carolina at Chapel Hill, B.S.
    • Franklin Pierce Law Center, J.D., magna cum laude
    • New York
    • U.S. District Court for the Eastern District of New York
    • U.S. District Court for the Southern District of New York
    • U.S. Patent and Trademark Office (USPTO)
    • New York
    • U.S. District Court for the Eastern District of New York
    • U.S. District Court for the Southern District of New York
    • U.S. Patent and Trademark Office (USPTO)
    • American Health Lawyers Association
    • New York State Bar Association
    • American Bar Association
    • American Health Lawyers Association
    • New York State Bar Association
    • American Bar Association

Jason's Insights

Client Alert | 2 min read | 04.24.24

FTC Continues Focus on Tracking Technologies and Personal Health Data

The Federal Trade Commission (FTC) recently entered into a settlement with Monument, Inc., an alcohol addiction treatment service, for allegedly disclosing users’ personal health data to third-party advertising platforms without consumer consent and violating their own website claims to consumers with respect to the disclosure of such data. The action follows other settlements by the FTC focused on tracking technologies collecting sensitive health information through web pages and web portals. “This action continues the FTC’s work to ensure strict limits on how firms handle sensitive health data, rather than putting the onus on consumers to protect themselves,” said Samuel Levine, Director of the FTC’s Bureau of Consumer Protection. “Following on the heels of actions against GoodRx, BetterHelp, and Premom, the market should be getting the message that consumer health data should be handled with extreme caution.”...

  • Speaking Engagement | 03.13.24

    "Best Practices in Recruiting for Health Equity: Designing a Successful Protocol for Recruitment," Clinical Trials Masterclass, New York, NY

  • Event | 03.13.24 - 03.14.24

    Clinical Trials Masterclass

  • Speaking Engagement | 03.13.24

    “Presentation of Attendee Clinical Trials With Focus on Recruiting,” Clinical Trials Masterclass, New York, NY

Insights

Speaking Engagement | 03.13.24

"Best Practices in Recruiting for Health Equity: Designing a Successful Protocol for Recruitment," Clinical Trials Masterclass, New York, NY

Speaking Engagement | 03.13.24

“Presentation of Attendee Clinical Trials With Focus on Recruiting,” Clinical Trials Masterclass, New York, NY
|

Jason's Insights

Client Alert | 2 min read | 04.24.24

FTC Continues Focus on Tracking Technologies and Personal Health Data

The Federal Trade Commission (FTC) recently entered into a settlement with Monument, Inc., an alcohol addiction treatment service, for allegedly disclosing users’ personal health data to third-party advertising platforms without consumer consent and violating their own website claims to consumers with respect to the disclosure of such data. The action follows other settlements by the FTC focused on tracking technologies collecting sensitive health information through web pages and web portals. “This action continues the FTC’s work to ensure strict limits on how firms handle sensitive health data, rather than putting the onus on consumers to protect themselves,” said Samuel Levine, Director of the FTC’s Bureau of Consumer Protection. “Following on the heels of actions against GoodRx, BetterHelp, and Premom, the market should be getting the message that consumer health data should be handled with extreme caution.”...

  • Speaking Engagement | 03.13.24

    "Best Practices in Recruiting for Health Equity: Designing a Successful Protocol for Recruitment," Clinical Trials Masterclass, New York, NY

  • Event | 03.13.24 - 03.14.24

    Clinical Trials Masterclass

  • Speaking Engagement | 03.13.24

    “Presentation of Attendee Clinical Trials With Focus on Recruiting,” Clinical Trials Masterclass, New York, NY